Compare DexCom, Inc. (DXCM) vs Williams Companies Inc (WMB) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
DexCom, Inc. vs Williams Companies Inc — how do they compare? DexCom, Inc. trades at $77.15 (market cap $28.06B), while Williams Companies Inc trades at $74.73 (market cap $90.97B). The key difference: Williams Companies Inc is far larger — about 3.2× DexCom, Inc.'s market cap, and Williams Companies Inc pays a 2.82% dividend while DexCom, Inc. pays none. Which is the better fit depends on your goals.
| DXCM | WMB | |
|---|---|---|
Market Cap | $28.06B | $90.97B |
Sector | Health | Energy |
52-Week High | $89.53 | $79.40 |
52-Week Low | $54.84 | $56.51 |
Enterprise Value | $27.03B | $120.35B |
Dividend Yield | — | 2.82% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
DXCM trades at $77.31, up 4.3% on the day, with a bullish technical outlook as it approaches resistance near $78. The company reported strong earnings beats in recent quarters, with Q1 2026 EPS of $0.56 surpassing expectations of $0.47. Revenue growth accelerated to $4.66 billion in 2025, while net income margin expanded to 17.93%. Recent regulatory approvals, including Health Canada authorization for the G7 15-day CGM, support continued international expansion.
The stock offers growth potential with analyst consensus price target of $84.33, though high valuation multiples (P/E 31.21) and competition in the CGM market present risks. Expansion into non-insulin Type 2 diabetes and pediatric markets could drive future revenue, but commercial uptake remains unproven. Institutional sentiment remains strongly bullish with 80% buy ratings.
Williams Companies (WMB) trades at $74.76, down 1.61% on the day, with a neutral technical outlook and strong analyst support. The stock shows robust profitability with a 23.4% net margin and 21.95% ROE, while recent news highlights a $5.34 billion Blackstone-led investment for power projects. Cash flow trends improved in 2025, with net cash flow turning positive to $3 million after a 2024 deficit.
WMB presents a favorable long-term outlook with a consensus price target of $85.67 and no sell ratings among analysts. Risks include high debt levels and exposure to natural gas price volatility, but the company's fee-based midstream model and strategic investments in energy infrastructure support dividend growth and earnings potential.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About DexCom, Inc.
Dexcom designs and commercializes continuous glucose monitoring systems for diabetics. CGM systems serve as an alternative to the traditional blood glucose meter process, and the company is evolving its CGM systems to include the disposable sensor and the durable receiver.
Read more on DXCM →About Williams Companies Inc
Williams is a midstream energy company that owns and operates the large Transco and Northwest pipeline systems and associated natural gas gathering, processing, and storage assets. In August 2018, the firm acquired the remaining 26% ownership of its limited partner, Williams Partners.
Read more on WMB →
